vancomycin has been researched along with fibrin in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 8 (50.00) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Cheesbrough, J; Cunningham, R | 1 |
| Bauer, D; Spohr, M; Traub, WH | 1 |
| Sande, MA; Scheld, WM; Vosbeck, K; Zak, O | 1 |
| Kang, SL; Rybak, MJ | 2 |
| Palmer, SM; Rybak, MJ | 2 |
| Buisson, M; Champliaud, D; Chavanet, P; Duong, M; Kazmierczak, A; Neuwirth, C; Pechinot, A; Portier, H | 1 |
| Fujimoto, K; Hayashi, T; Matsushita, M; Nabeshima, T; Nimura, Y; Nishikimi, N; Osada, T; Sakurai, T; Yamamura, K | 1 |
| Houlihan, HH; Mercier, RC; Rybak, MJ | 1 |
| Choi, JH; Choi, SM; Chun, HS; Kang, MW; Lee, DG; Shin, WS; Yim, DS; Yoo, JH | 1 |
| Burling, K; Ellington, MJ; Hyatt, AJ; Martin, KR; Rajan, MS; Tassoni, A | 1 |
| Chen, Q; Hou, T; Jin, H; Li, Z; Luo, F; Luobu, B; Xing, J; Xu, J | 1 |
| Chang, Z; Chen, Q; Hou, T; Li, Z; Luo, F; Wu, X; Xie, Z; Xing, J; Xu, J; Yu, B | 1 |
| Hauschild, T; Kosikowska, U; Marek, A; Śmiech, A; Stępień-Pyśniak, D; Wilczyński, J | 1 |
| Doan, VN; Tran, HLB; Truong, TT | 1 |
16 other study(ies) available for vancomycin and fibrin
| Article | Year |
|---|---|
Comparative activity of glycopeptide antibiotics against coagulase-negative staphylococci embedded in fibrin clots.
Topics: Blood Coagulation; Coagulase; Fibrin; Humans; Microbial Sensitivity Tests; Staphylococcus; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1992 |
Streptococcus faecalis: in vitro susceptibility to antimicrobial drugs, single and combined, with and without defibrinated human blood.
Topics: Animals; Anti-Bacterial Agents; Blood; Cattle; Enterococcus faecalis; Fibrin; Fusidic Acid; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Ofloxacin; Oxazines; Penicillins; Rabbits; Thienamycins; Vancomycin | 1986 |
Bacterial adhesion in the pathogenesis of infective endocarditis. Effect of subinhibitory antibiotic concentrations on streptococcal adhesion in vitro and the development of endocarditis in rabbits.
Topics: Animals; Anti-Bacterial Agents; Blood Platelets; Endocarditis, Bacterial; Enterococcus faecalis; Fibrin; Rabbits; Streptococcus sanguis; Vancomycin | 1981 |
Pharmacodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot model.
Topics: Blood Coagulation; Drug Therapy, Combination; Fibrin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Thrombosis; Vancomycin; Virginiamycin | 1995 |
Comparative in vitro activities of LY191145, a new glycopeptide, and vancomycin against Staphylococcus aureus and Staphylococcus-infected fibrin clots.
Topics: Anti-Bacterial Agents; Fibrin; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1995 |
Pharmacodynamics of once- or twice-daily levofloxacin versus vancomycin, with or without rifampin, against Staphylococcus aureus in an in vitro model with infected platelet-fibrin clots.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Blood Platelets; Colony Count, Microbial; Fibrin; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Rifampin; Staphylococcus aureus; Vancomycin | 1996 |
In-vivo activity and pharmacodynamics of cefotaxime in combination with vancomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.
Topics: Analysis of Variance; Animals; Cefotaxime; Disease Models, Animal; Drug Therapy, Combination; Fibrin; Half-Life; Microbial Sensitivity Tests; Penicillin Resistance; Pneumococcal Infections; Rabbits; Thrombosis; Treatment Outcome; Vancomycin | 1996 |
An evaluation of the bactericidal activity of ampicillin/sulbactam, piperacillin/tazobactam, imipenem or nafcillin alone and in combination with vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) in time-kill curves with infected fibrin
Topics: Ampicillin; Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Fibrin; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Nafcillin; Penicillanic Acid; Penicillins; Piperacillin; Staphylococcus aureus; Sulbactam; Tazobactam; Vancomycin | 1997 |
Subcutaneous tissue distribution of vancomycin from a fibrin glue/Dacron graft carrier.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bone Transplantation; Fibrin; Polyethylene Terephthalates; Rats; Staphylococcal Infections; Tissue Distribution; Vancomycin | 1997 |
Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.
Topics: Anti-Bacterial Agents; Area Under Curve; Blood Platelets; Cells, Cultured; Colony Count, Microbial; Drug Therapy, Combination; Fibrin; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Models, Biological; Staphylococcus aureus; Vancomycin | 1997 |
Efficacies of vancomycin, arbekacin, and gentamicin alone or in combination against methicillin-resistant Staphylococcus aureus in an in vitro infective endocarditis model.
Topics: Aminoglycosides; Anti-Bacterial Agents; Area Under Curve; Blood Coagulation; Colony Count, Microbial; Dibekacin; Drug Therapy, Combination; Endocarditis, Bacterial; Fibrin; Gentamicins; Methicillin Resistance; Microbial Sensitivity Tests; Models, Biological; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
Release of vancomycin and gentamicin from a contact lens versus a fibrin coating applied to a contact lens.
Topics: Anti-Bacterial Agents; Coated Materials, Biocompatible; Contact Lenses, Hydrophilic; Equipment Design; Eye Infections, Bacterial; Fibrin; Gentamicins; Humans; Keratitis; Vancomycin | 2012 |
Anti-infection tissue engineering construct treating osteomyelitis in rabbit tibia.
Topics: Animals; Anti-Infective Agents; Bone Substitutes; Combined Modality Therapy; Delayed-Action Preparations; Fibrin; Fracture Healing; Osteomyelitis; Rabbits; Tibia; Tibial Fractures; Tissue Scaffolds; Treatment Outcome; Vancomycin | 2013 |
An anti-infection tissue-engineered construct delivering vancomycin: its evaluation in a goat model of femur defect.
Topics: Animals; Anti-Bacterial Agents; Bone Transplantation; Disease Models, Animal; Femur; Fibrin; Goats; Humans; Staphylococcus aureus; Tissue Engineering; Transplants; Vancomycin; Wound Healing | 2013 |
Staphylococcus simulans associated with endocarditis in broiler chickens.
Topics: Animals; Anti-Infective Agents; Chickens; Drug Resistance, Bacterial; Endocarditis; Fibrin; Methicillin; Necrosis; Staphylococcal Infections; Staphylococcus; Vancomycin; Virulence Factors | 2017 |
Development of local vancomycin delivery system from fibrin gel to prevent
Topics: Anti-Bacterial Agents; Biofilms; Drug Delivery Systems; Fibrin; Gels; Humans; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2020 |